Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study investigated structural and functional magnetic resonance imaging abnormalities in hexanucleotide repeat expansion in
chromosome 9 open reading frame 72
(
C9orf72
) motor neuron disease (MND) relative to disease severity-matched sporadic MND cases. We enrolled 19
C9orf72
and 67 disease severity-matched sporadic MND patients, and 22 controls. Sporadic cases were grouped in patients with: no cognitive/behavioral deficits (sporadic-motor); same patterns of cognitive/behavioral impairment as
C9orf72
cases (sporadic-cognitive); shorter disease duration versus other sporadic groups (sporadic-early).
C9orf72
patients showed cerebellar and thalamic atrophy versus all sporadic cases. All MND patients showed motor, frontal, and temporoparietal cortical
thinning
and motor and extramotor white matter damage versus controls, independent of genotype and presence of cognitive impairment. Compared with sporadic-early,
C9orf72
patients revealed an occipital cortical
thinning
.
C9orf72
patients had enhanced visual network functional connectivity versus sporadic-motor and sporadic-early cases. Structural cerebellar and thalamic damage and posterior cortical alterations are the brain magnetic resonance imaging signatures of
C9orf72
MND. Frontotemporal cortical and widespread white matter involvement are likely to be an effect of the disease evolution rather than a
C9orf72
marker.
...
PMID:Structural and functional brain signatures of C9orf72 in motor neuron disease. 2866 9